Skip to main content
Have a personal or library account? Click to login
Late-onset hypogonadism: Review of the problem Cover

References

  1. Anonymous (2007). World Population Prospects the 2006 Revision. United Nations Highlights. New York. 67 pp.
  2. Beauchet, O. (2006). Testosterone and cognitive function: Current evidence of a relationship. European J. Endocrin., 155, 773-778.10.1530/eje.1.0230617132744
  3. Boonen, S., Vanderschueren, D., Cheng, X. G., Verbeke, G., Dequeker, J., Geusens, P., Broos, P., Bouillon R. (1997). Age-related (type II) femoral neck osteoporosis in men: Biochemical avidence for both hypovitaminosis D — and androgen deficiency — induced bone resorption. J. Bone Miner Res., 12(12), 2119-2126.10.1359/jbmr.1997.12.12.21199421246
  4. Brockenbrough, A. T., Dittrich, M. O., Page, S. T., Smith, T., Stivelman, J. C., Bremner, W. J. (2006). Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic renal disease. Amer. J. Kidney Dis., 47(2), 251-262.10.1053/j.ajkd.2005.10.02216431254
  5. Clapauch, R., Braga, D. J., Marinheiro, L. P., Buksman, S., Shrank, Y. (2008). Risk of late-onset hipogonadism (andropauze) in Brazilian men over 50 years of age with osteoporosis: Usefulness of screening questionnaires. Arg. Bras. Endokrinol. Metabol., 52(9), 1439-1447.10.1590/S0004-2730200800090000619197451
  6. Davidson, J. M., Chen, J. J., Crapo, L., Gray, G. D., Greenleaf, W. J., Catania, J. A. (1983). Hormonal changes and sexual function in aging men. J. Clin. Endocrinol. Metab., 57(1), 71-77.10.1210/jcem-57-1-716602143
  7. Ellegala, D. B., Alden, T. D., Couture, D. E., Vance, M. L., Maartens, N. F., Laws, E. R. Jr. (2003). Anemia, testosterone and pituitary adenoma in men. J. Neurosug., 98(5), 974-977.10.3171/jns.2003.98.5.097412744356
  8. Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., McKinlay, J. B. (2002). Age trends on the level of serum testosterone and other hormones in middle-aged men: Longitudinal result from Massachusetts male aging study. J. Clin. Endocrinol Metabol., 87(2), 589-598.10.1210/jcem.87.2.820111836290
  9. Fox, C. S., Hwang, S. J., Massaro, J. M., Lieb, K., Vasan, R. S., O'Donnell, C. J., Hoffmann, U. (2009) Relation of subcutaneous and visceral adipose tissue to coronary and abdominal aortic calcium (from the Framingham Heart Study). Amer. J. Cardiol., 104(4), 543-547.10.1016/j.amjcard.2009.04.019272372419660609
  10. Gooren, L. J. (2009) Late-onset hypogonadism. Front Horm. Res., 37, 62-73.
  11. Grossmann, M., Panagiotopolous, S., Sharpe, K., MacIsaac, R. J., Clarke, S., Zajac, J. D., Jerums G., Thomas M. C. (2009) Low testosterone and anaemia in men with type 2 diabetes. Clin. Endocrinol. (Oxf.), 70(4), 547-553.10.1111/j.1365-2265.2008.03357.x18702678
  12. Hak, A. E., Witteman, J. C., de Jong, F. H., Geerlings, M. I., Hofman, A., Pols, H. A. (2002) Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: The Rotterdam study. J. Clin. Endocrinol. Metab., 87(8), 3632-3639.10.1210/jcem.87.8.876212161487
  13. Ho, J. S., Cannaday, J. J., Barlow, C. E., Willis, B., Haskell, W. L., FitzGerald, S. J. (2009) Comparative relation of general, central, and visceral adiposity measures for coronary artery calcium in subjects without previous coronary events. Amer. J. Cardiol., 104(7), 943-946.10.1016/j.amjcard.2009.05.04719766761
  14. Isidori, A. M., Giannetta, E., Pozza, C., Bonifacio, V., Isidori, A. (2005) Androgens, cardiovaskular disease and osteoporosis. J. Endocrinol. Invest., 28(10), 73-79.
  15. Jaffe, M. D. (1977). Effect of testosterone cypionate on postexercise ST segment depression. Brit. Heart J., 39, 1217-1222.10.1136/hrt.39.11.1217483399337982
  16. Kapoor, D., Goodwin, E., Channer, K. S., Jones, T. H. (2006). Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur. J. Endocrin., 154(6), 899-906.10.1530/eje.1.0216616728551
  17. Manolakou, P., Angelopoulou, R., Bakoyiannis, C., Bastounis, E. (2009). The effects of endogenous and exogenous androgens on cardiovascular disease risk factors and progression. Reprod. Biol. Endocrinol., 7, 44.10.1186/1477-7827-7-44269312519433001
  18. Mathur, A., Malkin, C., Saeed, B., Muthusamy, R., Jones, T. H., Channer, K. (2009). Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men. Eur. J. Endocrinol., 161(3), 443-449.10.1530/EJE-09-009219542238
  19. Morales, A., Lunenfeld, B. (2002). Investigation, treatment and monitoring of late — onset hypogonadism in males. Official recomendation of ISSAM. International Society for the Study of the Aging Male. Aging Male, 5(2), 74-86.10.1080/tam.5.2.74.86
  20. Morley, J. E., Baumgartner, R. N., Roubenoff, R., Mayer, J., Nair, K. S. (2001). Sarcopenia. J Lab. Clin. Med., 137(4), 231-243.10.1067/mlc.2001.11350411283518
  21. Neaves, W. B., Johnson, L., Porter, J. C., Parker, C. R. Jr, Petty, C. S. (1984). Leyding cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J. Clin. Endocrinol. Metab., 55, 756-763.10.1210/jcem-59-4-7566434579
  22. Nettleship, J. E., Jones, R. D., Channer, K. S., Jones, T. H. (2009). Testosterone and coronary artery disease. Front Horm. Res., 37, 91-107.10.1159/00017604719011291
  23. Phillips, G. B., Pinkernell, B. H., Jing, T. Y. (1994). The association of hypotestosteronemia with coronary artery disease. Arterioscler. Thromb., 14(5), 701-706.10.1161/01.ATV.14.5.701
  24. Sarkar, N. N. (2009). Hormonal profiles behind the heart of a man. Cardiol J., 16(4), 300-306.
  25. Schweiger, U., Deuschle, M., Weber, B., Korner, A., Lammers, C. H., Schmider, J., Gotthardt, U., Heuser, I. (1999). Testosterone, gonadotropin and cortisol secretion in male patient with major depression. Psyhosom Med., 61(3), 292-296.10.1097/00006842-199905000-00007
  26. Stanley, H. L., Schmit, B. P., Poses, R. M., Deiss, W. P. (1991). Does hypogonadism coutribute to the accurensy of a minimal trauma hip fracture in elderly men? J. Amer. Geriatr. Soc., 39(8), 766-771.10.1111/j.1532-5415.1991.tb02698.x
  27. Wang, C., Nieschlag, E., Swerdloff, R., Behre, H. M., Hellstrom, W. J., Gooren, L. J., Kaufman, J. M., Legros, J. J., Lunenfeld, B., Morales, A., Morley, J. E., Schulman, C., Thompson, I. M., Weidner, W., Wu, F. C. (2009). ISA, ISSAM, EAU, EAA and ASA recomendation: Investigation, treatment and monitoring of late — onset hypogonadism in males. J. Androl., 30(1), 1-9.10.2164/jandrol.108.006486
  28. Webb, C. M., Adamson, D. L., de Zeigler, D., Collins, P. (1999). Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Amer. J. Cardiol., 83, 437-439.10.1016/S0002-9149(98)00880-7
  29. Yassin, A. A., Saad, F. (2007). Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only. J Sex Med., 4(2), 497-501.10.1111/j.1743-6109.2007.00442.x17367445
  30. Yeap, B. B. Beilin, J., Shi, Z., Knuiman, M. W., Olynyk, J. K., Bruce, D. G., Milward, E. A. (2008). Serum testosterone levels correlate with haemoglobin in middle-aged and older men. Intern Med J., 16.
  31. Zitzman, M., Nieschlag, E. (2003). Hypogonadism in the elderly men. Internist (Berl)., 44(10), 1313-1321.
  32. Бутрова С. (1999). Синдром инсулинрезистентности при абдоминальном ожирении [Insulin resistance syndrome in case of abdominal adiposity]. Лечащий врач, - 7, 32-34 (in Russian).
DOI: https://doi.org/10.2478/v10046-010-0028-3 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 93 - 97
Published on: Jan 25, 2011
In partnership with: Paradigm Publishing Services

© 2011 Anatolijs Požarskis, Juris Ērenpreiss, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons License.

Volume 64 (2010): Issue 3-4 (August 2010)